Global Drug Safety Solutions and Pharmacovigilance Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report ID: ARS10663 | Category: Healthcare | Pages: 106 | Format: PDF | Published Date: December 18,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3350.00 Multi User-$5700.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for Drug Safety Solutions and Pharmacovigilance, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Safety Solutions and Pharmacovigilance.

The Drug Safety Solutions and Pharmacovigilance market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Safety Solutions and Pharmacovigilance market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Safety Solutions and Pharmacovigilance manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Drug Safety Solutions and Pharmacovigilance market size in 2022 is 7826.5 million US dollars, and it is expected to be 13018.5 million US dollars by 2029, with a compound annual growth rate of 7.54% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Drug Safety Solutions and Pharmacovigilance market include PPD Inc (U.S.), Drug Safety Solutions Limited (U.S.), C3i (U.S.), Worldwide Clinical Trials (U.S.), and Bioclinica (U.S.). The share of the top 3 players in the Drug Safety Solutions and Pharmacovigilance market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Drug Safety Solutions and Pharmacovigilance market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Standard Form accounted for XX% of Drug Safety Solutions and Pharmacovigilance market in 2022. Customized Form share of XX%.
Biotechnology and Pharmaceuticals accounted for XX% of the Drug Safety Solutions and Pharmacovigilance market in 2022. Contract Research Organizations (CROS) accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Drug Safety Solutions and Pharmacovigilance market status and forecast by region.
Chapters 2-3: Segmented the global Drug Safety Solutions and Pharmacovigilance market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Drug Safety Solutions and Pharmacovigilance market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Drug Safety Solutions and Pharmacovigilance market country segmentation data.
Chapter 10: Analyzes the main companies in the Drug Safety Solutions and Pharmacovigilance industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
PPD Inc (U.S.)
Drug Safety Solutions Limited (U.S.)
C3i (U.S.)
Worldwide Clinical Trials (U.S.)
Bioclinica (U.S.)
United Biosource LLC (U.S.)
Ennov (Hong Kong)
AB Cube S.A.S. (France)
Labcorp Drug Development (U.S.)
Accenture (Ireland)
ICON plc (U.S.)
Ergomed plc (U.K.)
IQVIA (U.S.)
Genpact (U.S.)
Cognizant (U.S.)
Parexel International Corporation (U.S.)
ArisGlobal (U.S.)

Types list
Standard Form
Customized Form

Application list
Biotechnology and Pharmaceuticals
Contract Research Organizations (CROS)
Hospitals
KPOs/BPOs
Healthcare Providers

Table of Content

1 Drug Safety Solutions and Pharmacovigilance Market Overview
1.1 Drug Safety Solutions and Pharmacovigilance Product Overview
1.1.1 Drug Safety Solutions and Pharmacovigilance Product Scope
1.1.2 Drug Safety Solutions and Pharmacovigilance Market Status and Outlook
1.2 Global Drug Safety Solutions and Pharmacovigilance Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2029)
1.4 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Region (2018-2023)
1.5 Global Drug Safety Solutions and Pharmacovigilance Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
1.6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
1.6.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
1.6.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2018-2029)
2 Drug Safety Solutions and Pharmacovigilance Market Overview by Type
2.3 Global Drug Safety Solutions and Pharmacovigilance Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2018-2023)
2.5 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Type
2.6.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Type
2.6.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Type
2.6.5 Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Type
3 Drug Safety Solutions and Pharmacovigilance Market Overview by Application
3.3 Global Drug Safety Solutions and Pharmacovigilance Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2018-2023)
3.5 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Application
3.6.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Application
3.6.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Application
3.6.5 Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market Size Breakdown by Application
4 Drug Safety Solutions and Pharmacovigilance Competition Analysis by Players
4.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2022)
4.3 Date of Key Players Enter into Drug Safety Solutions and Pharmacovigilance Market
4.4 Global Top Players Drug Safety Solutions and Pharmacovigilance Headquarters and Area Served
4.5 Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Safety Solutions and Pharmacovigilance Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Drug Safety Solutions and Pharmacovigilance Market Segment by Country
5.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Drug Safety Solutions and Pharmacovigilance Market Segment by Country
6.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Segment by Country
7.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Drug Safety Solutions and Pharmacovigilance Market Segment by Country
8.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market Segment by Country
9.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1  PPD Inc (U.S.)
10.1.1 PPD Inc (U.S.) Information
10.1.2 Business Overview
10.1.3 PPD Inc (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.1.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.1.5 PPD Inc (U.S.) Recent Development
10.2  Drug Safety Solutions Limited (U.S.)
10.2.1 Drug Safety Solutions Limited (U.S.) Information
10.2.2 Business Overview
10.2.3 Drug Safety Solutions Limited (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.2.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.2.5 Drug Safety Solutions Limited (U.S.) Recent Development
10.3  C3i (U.S.)
10.3.1 C3i (U.S.) Information
10.3.2 Business Overview
10.3.3 C3i (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.3.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.3.5 C3i (U.S.) Recent Development
10.4  Worldwide Clinical Trials (U.S.)
10.4.1 Worldwide Clinical Trials (U.S.) Information
10.4.2 Business Overview
10.4.3 Worldwide Clinical Trials (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.4.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.4.5 Worldwide Clinical Trials (U.S.) Recent Development
10.5  Bioclinica (U.S.)
10.5.1 Bioclinica (U.S.) Information
10.5.2 Business Overview
10.5.3 Bioclinica (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.5.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.5.5 Bioclinica (U.S.) Recent Development
10.6  United Biosource LLC (U.S.)
10.6.1 United Biosource LLC (U.S.) Information
10.6.2 Business Overview
10.6.3 United Biosource LLC (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.6.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.6.5 United Biosource LLC (U.S.) Recent Development
10.7  Ennov (Hong Kong)
10.7.1 Ennov (Hong Kong) Information
10.7.2 Business Overview
10.7.3 Ennov (Hong Kong) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.7.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.7.5 Ennov (Hong Kong) Recent Development
10.8  AB Cube S.A.S. (France)
10.8.1 AB Cube S.A.S. (France) Information
10.8.2 Business Overview
10.8.3 AB Cube S.A.S. (France) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.8.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.8.5 AB Cube S.A.S. (France) Recent Development
10.9  Labcorp Drug Development (U.S.)
10.9.1 Labcorp Drug Development (U.S.) Information
10.9.2 Business Overview
10.9.3 Labcorp Drug Development (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.9.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.9.5 Labcorp Drug Development (U.S.) Recent Development
10.10  Accenture (Ireland)
10.10.1 Accenture (Ireland) Information
10.10.2 Business Overview
10.10.3 Accenture (Ireland) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.10.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.10.5 Accenture (Ireland) Recent Development
10.11  ICON plc (U.S.)
10.11.1 ICON plc (U.S.) Information
10.11.2 Business Overview
10.11.3 ICON plc (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.11.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.11.5 ICON plc (U.S.) Recent Development
10.12  Ergomed plc (U.K.)
10.12.1 Ergomed plc (U.K.) Information
10.12.2 Business Overview
10.12.3 Ergomed plc (U.K.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.12.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.12.5 Ergomed plc (U.K.) Recent Development
10.13  IQVIA (U.S.)
10.13.1 IQVIA (U.S.) Information
10.13.2 Business Overview
10.13.3 IQVIA (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.13.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.13.5 IQVIA (U.S.) Recent Development
10.14  Genpact (U.S.)
10.14.1 Genpact (U.S.) Information
10.14.2 Business Overview
10.14.3 Genpact (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.14.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.14.5 Genpact (U.S.) Recent Development
10.15  Cognizant (U.S.)
10.15.1 Cognizant (U.S.) Information
10.15.2 Business Overview
10.15.3 Cognizant (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.15.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.15.5 Cognizant (U.S.) Recent Development
10.16  Parexel International Corporation (U.S.)
10.16.1 Parexel International Corporation (U.S.) Information
10.16.2 Business Overview
10.16.3 Parexel International Corporation (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.16.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.16.5 Parexel International Corporation (U.S.) Recent Development
10.17  ArisGlobal (U.S.)
10.17.1 ArisGlobal (U.S.) Information
10.17.2 Business Overview
10.17.3 ArisGlobal (U.S.) Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin
10.17.4 Drug Safety Solutions and Pharmacovigilance Products Offered
10.17.5 ArisGlobal (U.S.) Recent Development
11 Drug Safety Solutions and Pharmacovigilance Market Dynamics
11.1 Drug Safety Solutions and Pharmacovigilance Industry Trends
11.2 Drug Safety Solutions and Pharmacovigilance Growth Drivers
11.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
11.4 Drug Safety Solutions and Pharmacovigilance Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Drug Safety Solutions and Pharmacovigilance Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?